Cardiac surgery in patients infected with the human immunodeficiency virus

Annals of Thoracic Surgery

Volumn 76, Issue 4, 2003, Pages 1114-1118

  Trachiotis, Gregory D ^a   Alexander, E Pendleton ^a,b   Benator, Debra ^a   Gharagozloo, Farid ^a   Sundt, Thoralf ^c   Baumgartner, William ^c  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b Cardiothoracic Surgery   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR;

ABDOMINAL DISTENSION; ADULT; AORTA VALVE REPLACEMENT; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DEATH; FEMALE; FOLLOW UP; HEADACHE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; KIDNEY FAILURE; MALE; MEDICAL RECORD; MITRAL VALVE REPLACEMENT; MORBIDITY; MORTALITY; NAUSEA; OPERATING ROOM PERSONNEL; OPPORTUNISTIC INFECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SEROCONVERSION; STATISTICAL ANALYSIS; SURGICAL RISK; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0141674666     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04756-2     Document Type: Article

References (20)

1. Karon JM, Flemming PL, Stecker RW, De Lock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-8.
2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
3. Lederman MM, Valdez H. Immune restoration with anti-retroviral therapies. Implications for clinical management. JAMA 2000;284:223-8.
4. Hidalgo JA, MacArthur RD, Leone LR. An overview of HIV infection and AIDS: etiology, pathogenesis, diagnosis, epidemiology, and occupational exposure. Semin Thorac Cardiovasc Surg 2000;12:130-9.
5. Cotton P. AIDS giving rise to cardiac problems. JAMA 1990;263:2149.
6. Yumis NA, Stone VE. Cardiac manifestation of AIDS: a review of disease spectrum and clinical management. J Acqui Immune Defic Syndr Hum Retroviral 1998;18:145-54.
7. Frater RW, Sisto D, Condit D. Cardiac surgery in human immunodeficiency virus (HIV) carriers. Eur J Cardiothoracic Surg 1989;3:146-50.
8. Rerkpattanapipat P, Wongprapurat N, Jacobs CE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Arch Intern Med 2000;160:602-8.
9. Malnick S, Goland S. Dilated cardiomyopathy in HIV infected patients. N Engl J Med 1999;4:732-3.
10. Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med 2001;94:384-90.
11. Passalaris JD, Sepkowitz KA, Glesby MJ. Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis 2000;31:787-97.
12. Henry K, Mehoe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328.
13. Sullivan AK, Nelson MR, Moyle GJ, et al. Coronary artery disease occurring with protease inhibitor therapy. Int J STD AIDS 1998;9:711-12.
14. Hayes P, Muller D, Kuchar D. Left main coronary artery disease in a 40 year old man receiving HIV protease inhibitors. Aust NZ J Med 2000;30:92-3.
15. Monsuez JJ, Gallet B, Escant L, et al. Clinical outcome after coronary events in patients treated with HIV-protease inhibitors. Eur Heart J 2000;21:2079-80.
16. Friedl AC, Jost CH, Schalcher L, et al. Acceleration of confirmed coronary artery disease among HIV infected patients on potent anti-retroviral therapy. AIDS 2000;14:2790-2.
17. Frater RWM. Cardiac surgery and the human immunodeficiency virus. Semin Thorac Cardiovasc Surg 2000;122:145-7.
18. Imanaka K, Takomoto S, Kimuric S, et al. Coronary artery bypass grafting in a patient with human immunodeficiency virus: role of peri-operative active anti-retroviral therapy. Jpn Circ J 199;63:423-4.
19. Flinn DR, Tyras DH, Wallack MK. Coronary artery bypass grafting in patients with human immunodeficiency virus. J Card Surg 1997;12:98-101.
20. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post-exposure prophylaxis. MMWR 2001;50:1-52.